Evolution of Type IV CRISPR-Cas Systems: Insights from CRISPR Loci in Integrative Conjugative Elements of Acidithiobacillia

被引:20
|
作者
Moya-Beltran, Ana [1 ,2 ]
Makarova, Kira S. [3 ]
Acuna, Lillian G. [1 ,7 ]
Wolf, Yuri, I [3 ]
Covarrubias, Paulo C. [1 ,8 ]
Shmakov, Sergey A. [3 ]
Silva, Cristian [1 ]
Tolstoy, Igor [3 ]
Johnson, D. Barrie [4 ,5 ]
Koonin, Eugene, V [3 ]
Quatrini, Raquel [1 ,2 ,6 ]
机构
[1] Fdn Ciencio & Vida, Santiago, Chile
[2] Millennium Nucleus Biol Intestinal Microbiota, ANID Millennium Sci Initiat Program, Santiago, Chile
[3] NLM, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA
[4] Bangor Univ, Sch Nat Sci, Bangor, Gwynedd, Wales
[5] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England
[6] Univ San Sebastian, Fac Med & Ciencia, Santiago, Chile
[7] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab RNAs Bacterianos, Santiago, Chile
[8] Univ Andres Bello, Interdisciplinary Ctr Aquaculture Res INCAR, Vina Del Mar, Chile
来源
CRISPR JOURNAL | 2021年 / 4卷 / 05期
基金
美国国家卫生研究院;
关键词
MULTIPLE SEQUENCE ALIGNMENT; CLASSIFICATION; GENE; IDENTIFICATION; PREDICTION; BACTERIAL;
D O I
10.1089/crispr.2021.0051
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Type IV CRISPR-Cas are a distinct variety of highly derived CRISPR-Cas systems that appear to have evolved from type III systems through the loss of the target-cleaving nuclease and partial deterioration of the large subunit of the effector complex. All known type IV CRISPR-Cas systems are encoded on plasmids, integrative and conjugative elements (ICEs), or prophages, and are thought to contribute to competition between these elements, although the mechanistic details of their function remain unknown. There is a clear parallel between the compositions and likely origin of type IV and type I systems recruited by Tn7-like transposons and mediating RNA-guided transposition. We investigated the diversity and evolutionary relationships of type IV systems, with a focus on those in Acidithiobacillia, where this variety of CRISPR is particularly abundant and always found on ICEs. Our analysis revealed remarkable evolutionary plasticity of type IV CRISPR-Cas systems, with adaptation and ancillary genes originating from different ancestral CRISPR-Cas varieties, and extensive gene shuffling within the type IV loci. The adaptation module and the CRISPR array apparently were lost in the type IV ancestor but were subsequently recaptured by type IV systems on several independent occasions. We demonstrate a high level of heterogeneity among the repeats with type IV CRISPR arrays, which far exceed the heterogeneity of any other known CRISPR repeats and suggest a unique adaptation mechanism. The spacers in the type IV arrays, for which protospacers could be identified, match plasmid genes, in particular those encoding the conjugation apparatus components. Both the biochemical mechanism of type IV CRISPR-Cas function and their role in the competition among mobile genetic elements remain to be investigated.
引用
收藏
页码:656 / 672
页数:17
相关论文
共 50 条
  • [41] CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids
    Pinilla-Redondo, Rafael
    Russel, Jakob
    Mayo-Munoz, David
    Shah, Shiraz A.
    Garrett, Roger A.
    Nesme, Joseph
    Madsen, Jonas S.
    Fineran, Peter C.
    Sorensen, Soren J.
    NUCLEIC ACIDS RESEARCH, 2022, 50 (08) : 4315 - 4328
  • [42] Diversity of CRISPR-Cas type II-A systems in Streptococcus anginosus
    Bauer, Richard
    Haider, Dorina
    Grempels, Aline
    Roscher, Rebecca
    Mauerer, Stefanie
    Spellerberg, Barbara
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [43] The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
    Chylinski, Krzysztof
    Le Rhun, Anais
    Charpentier, Emmanuelle
    RNA BIOLOGY, 2013, 10 (05) : 726 - 737
  • [44] CRISPR-Cas adaptive immunity and developments in CRISPR-Cas applications Reply to comments on "Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems"
    Cooper, Edwin L.
    Overstreet, Nicola
    PHYSICS OF LIFE REVIEWS, 2014, 11 (01) : 149 - 151
  • [45] Mechanistic and evolutionary insights into a type V-M CRISPR-Cas effector enzyme
    Omura, Satoshi N.
    Nakagawa, Ryoya
    Sudfeld, Christian
    Warren, Ricardo Villegas
    Wu, Wen Y.
    Hirano, Hisato
    Laffeber, Charlie
    Kusakizako, Tsukasa
    Kise, Yoshiaki
    Lebbink, Joyce H. G.
    Itoh, Yuzuru
    van der Oost, John
    Nureki, Osamu
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2023, 30 (08) : 1172 - +
  • [46] Targeting of temperate phages drives loss of type I CRISPR-Cas systems
    Rollie, Clare
    Chevallereau, Anne
    Watson, Bridget N. J.
    Chyou, Te-yuan
    Fradet, Olivier
    McLeod, Isobel
    Fineran, Peter C.
    Brown, Chris M.
    Gandon, Sylvain
    Westra, Edze R.
    NATURE, 2020, 578 (7793) : 149 - +
  • [47] Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers
    Niewoehner, Ole
    Garcia-Doval, Carmela
    Rostol, Jakob T.
    Berk, Christian
    Schwede, Frank
    Bigler, Laurent
    Hall, Jonathan
    Marraffini, Luciano A.
    Jinek, Martin
    NATURE, 2017, 548 (7669) : 543 - +
  • [48] Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression
    Luo, Michelle L.
    Mullis, Adam S.
    Leenay, Ryan T.
    Beisel, Chase L.
    NUCLEIC ACIDS RESEARCH, 2015, 43 (01) : 674 - 681
  • [49] Adaptation by Type III CRISPR-Cas Systems: Breakthrough Findings and Open Questions
    Zhang, Xinfu
    An, Xinmin
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [50] Targeted Transcriptional Modulation with Type I CRISPR-Cas Systems in Human Cells
    Pickar-Oliver, Adrian
    Black, Joshua B.
    Lewis, Mae M.
    Mutchnick, Kevin J.
    Barrera, Alejandro
    Bartelt, Luke C.
    Reddy, Timothy E.
    Beisel, Chase L.
    Barrangou, Rodolphe
    Gersbach, Charles A.
    MOLECULAR THERAPY, 2019, 27 (04) : 295 - 295